Incentives for COVID-19 vaccination

Noel T Brewer^{1

2}, Alison M Buttenheim³, Chelsea V Clinton^{4

5}, Michelle M Mello^{6

7

8}, Regina M Benjamin⁹, Timothy Callaghan¹⁰, Arthur Caplan¹¹, Richard M Carpiano¹², Renee DiResta¹³, Jad A Elharake^{14

15}, Lisa C Flowers¹⁶, Alison P Galvani¹⁷, Peter J Hotez^{18

19

20

21

22}, Rekha Lakshmanan²³, Yvonne A Maldonado²⁴, Saad B Omer^{14

15

25

26}, Daniel A Salmon²⁷, Jason L Schwartz²⁸, Joshua M Sharfstein²⁹, Douglas J Opel^{30

31}

Affiliations

¹ Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina, 325 Rosenau Hall CB7440, Chapel Hill, NC 27599, USA.
² Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
³ Department of Family and Community Health, University of Pennsylvania School of Nursing, and Center for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia, PA, USA.
⁴ Department of Health Policy and Management, Mailman School of Public Health, Columbia University, New York, NY, USA.
⁵ Clinton Foundation, New York, NY, USA.
⁶ Stanford Law School and Stanford School of Medicine, Stanford University, USA.
⁷ Department of Health Policy, Stanford University School of Medicine, Stanford, CA, USA.
⁸ Freeman Spogli Institute for International Studies, Stanford University, Stanford, CA, USA.
⁹ Gulf States Health Policy Center, Bayou La Batre, AL, USA.
¹⁰ Department of Health Policy and Management, School of Public Health, Texas A&M University, College Station, TX, USA.
¹¹ New York University Langone School of Medicine, New York University, New York, NY, USA.
¹² School of Public Policy, University of California, Riverside, CA, USA.
¹³ Stanford Internet Observatory, Stanford University, Stanford, CA, USA.
¹⁴ Yale Institute for Global Health, New Haven, CT, USA.
¹⁵ Department of Internal Medicine (Infectious Diseases), Yale School of Medicine, New Haven, CT, USA.
¹⁶ Department of Obstetrics and Gynecology, Emory University, Atlanta, Georgia, USA.
¹⁷ Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT, USA.
¹⁸ Texas Children's Center for Vaccine Development, Departments of Pediatrics and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA.
¹⁹ Department of Biology, Baylor University, Waco, TX, USA.
²⁰ Hagler Institute for Advanced Study at Texas A&M University, College Station, TX, USA.
²¹ James A Baker III Institute for Public Policy, Rice University, Houston, TX, USA.
²² Scowcroft Institute of International Affairs, Bush School of Government and Public Service, Texas A&M University, College Station, TX, USA.
²³ The Immunization Partnership, Houston, TX, USA.
²⁴ Stanford University School of Medicine, Stanford, CA, USA.
²⁵ Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
²⁶ Yale School of Nursing, Orange, CT, USA.
²⁷ Department of International Health, Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
²⁸ Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA.
²⁹ Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
³⁰ Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.
³¹ Seattle Children's Research Institute, Seattle, WA, USA.

PMID: 35229080
PMCID: PMC8866051
DOI: 10.1016/j.lana.2022.100205

Incentives for COVID-19 vaccination

Noel T Brewer et al. Lancet Reg Health Am. 2022 Apr.

. 2022 Apr:8:100205.

doi: 10.1016/j.lana.2022.100205. Epub 2022 Feb 24.

Authors

Affiliations

¹ Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina, 325 Rosenau Hall CB7440, Chapel Hill, NC 27599, USA.
² Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
³ Department of Family and Community Health, University of Pennsylvania School of Nursing, and Center for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia, PA, USA.
⁴ Department of Health Policy and Management, Mailman School of Public Health, Columbia University, New York, NY, USA.
⁵ Clinton Foundation, New York, NY, USA.
⁶ Stanford Law School and Stanford School of Medicine, Stanford University, USA.
⁷ Department of Health Policy, Stanford University School of Medicine, Stanford, CA, USA.
⁸ Freeman Spogli Institute for International Studies, Stanford University, Stanford, CA, USA.
⁹ Gulf States Health Policy Center, Bayou La Batre, AL, USA.
¹⁰ Department of Health Policy and Management, School of Public Health, Texas A&M University, College Station, TX, USA.
¹¹ New York University Langone School of Medicine, New York University, New York, NY, USA.
¹² School of Public Policy, University of California, Riverside, CA, USA.
¹³ Stanford Internet Observatory, Stanford University, Stanford, CA, USA.
¹⁴ Yale Institute for Global Health, New Haven, CT, USA.
¹⁵ Department of Internal Medicine (Infectious Diseases), Yale School of Medicine, New Haven, CT, USA.
¹⁶ Department of Obstetrics and Gynecology, Emory University, Atlanta, Georgia, USA.
¹⁷ Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT, USA.
¹⁸ Texas Children's Center for Vaccine Development, Departments of Pediatrics and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA.
¹⁹ Department of Biology, Baylor University, Waco, TX, USA.
²⁰ Hagler Institute for Advanced Study at Texas A&M University, College Station, TX, USA.
²¹ James A Baker III Institute for Public Policy, Rice University, Houston, TX, USA.
²² Scowcroft Institute of International Affairs, Bush School of Government and Public Service, Texas A&M University, College Station, TX, USA.
²³ The Immunization Partnership, Houston, TX, USA.
²⁴ Stanford University School of Medicine, Stanford, CA, USA.
²⁵ Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
²⁶ Yale School of Nursing, Orange, CT, USA.
²⁷ Department of International Health, Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
²⁸ Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA.
²⁹ Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
³⁰ Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.
³¹ Seattle Children's Research Institute, Seattle, WA, USA.

PMID: 35229080
PMCID: PMC8866051
DOI: 10.1016/j.lana.2022.100205

No abstract available

PubMed Disclaimer

Conflict of interest statement

The Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA is co-hosted by the Yale Institute for Global Health and the Baylor College of Medicine. The Commissioners are Saad B Omer, Regina M Benjamin, Noel T Brewer, Alison M Buttenheim, Timothy Callaghan, Arthur Caplan, Richard M Carpiano, Chelsea Clinton, Renee DiResta, Jad A Elharake, Lisa C Flowers, Alison P Galvani, Rekha Lakshmanan, Yvonne A Maldonado, Michelle M Mello, Douglas J Opel, Daniel A Salmon, Jason L Schwartz, Joshua M Sharfstein, and Peter J Hotez. PJH is a developer of a COVID-19 vaccine construct, which was licensed by Baylor College of Medicine to Biological E Ltd, a commercial vaccine manufacturer for scale-up, production, testing and licensure. NTB reports personal fees from WHO, CDC, and Merck outside the submitted work. RMC reports receiving research grant funding from Novo Nordisk Foundation (Denmark), outside the submitted work. RL reports grants from Pfizer, GlaxoSmithKline, Sanofi Pasteur, and Merck and personal fees from BIO, outside the submitted work. YAM is a member of a Data Safety Monitoring Board for Pfizer and a site PI for a Pfizer vaccine trial, outside the submitted work. MMM reports personal fees from law firms representing retail pharmacies and generic drug companies that have sued other drug companies for antitrust law violations, outside the submitted work, and serves as an advisor to Verily Life Sciences LLC on an app designed to facilitate safe return to work and school during COVID-19. DJO reports grants from the U.S. National Institutes of Health, outside the submitted work. DAS reports grants from Merck and personal fees from Pfizer and Janssen, outside the submitted work. The other authors declare no competing interests.

References

1. Fisher E.B., Green L., Calvert A.L., Glasgow R.E. Associative Learning and Conditioning Theory: Human and Non-human Applications. Oxford University Press; Oxford: 2011. Incentives in the modification and cessation of cigarette smoking; pp. 321–342.
1. CDC community guide to community preventive services. Downloaded 8/6/21.
1. Campos-Mercade P., Meier A.N., Schneider F.H., Meier S., Pope D., Wengström E. Monetary incentives increase COVID-19 vaccinations. Science. 2021 eabm0475. - PMC - PubMed
1. Wong C.A., Pilkington W., Doherty I.A., et al. Guaranteed financial incentives for COVID-19 vaccination: a pilot program in North Carolina, US. JAMA Intern Med. 2021 - PMC - PubMed
1. Walkey A.J., Law A., Bosch N.A. Lottery-based incentive in Ohio and COVID-19 vaccination rates. JAMA. 2021;326:766–767. - PMC - PubMed

Grants and funding

UL1 TR001863/TR/NCATS NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Incentives for COVID-19 vaccination

Affiliations

Incentives for COVID-19 vaccination

Authors

Affiliations

Conflict of interest statement

References

Grants and funding

LinkOut - more resources

Full Text Sources